Jing Xiao

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua et al. · Journal of Medicinal Chemistry · 2024 · 56 citations · Full text

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang et al. · European Journal of Medicinal Chemistry · 2022 · 45 citations · Full text

Systematic Exploration, Medicine, Antiviral Drug Development +8

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

Yuying Ma, Kai S. Yang, Zhi Geng et al. · European Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

Medicine, Antiviral Drug Development, Multi-pronged Evaluation +7

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Zhi Geng, Sandeep Atla, Namir Shaabani et al. · Journal of Medicinal Chemistry · 2023 · 20 citations · Full text

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Kaustav Khatua, Yugendar R. Alugubelli, Kai S. Yang et al. · Antiviral Research · 2024 · 10 citations · Full text